Relapse-free cure from multidrug-resistant tuberculosis in Germany

Eur Respir J. 2018 Feb 21;51(2):1702122. doi: 10.1183/13993003.02122-2017. Print 2018 Feb.
No abstract available

Publication types

  • Letter
  • Multicenter Study
  • Observational Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antitubercular Agents / therapeutic use
  • Extensively Drug-Resistant Tuberculosis / drug therapy*
  • Follow-Up Studies
  • Germany / epidemiology
  • Humans
  • Prospective Studies
  • Recurrence
  • Remission Induction
  • Treatment Outcome
  • Tuberculosis, Multidrug-Resistant / drug therapy*
  • Tuberculosis, Multidrug-Resistant / epidemiology
  • Tuberculosis, Pulmonary / drug therapy

Substances

  • Antitubercular Agents